RT Journal Article
SR Electronic
T1 Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.31.20183533
DO 10.1101/2020.08.31.20183533
A1 Bardai, Ghalib
A1 Ouellet, Jean A.
A1 Engelhardt, Thomas
A1 Bertolizio, Gianluca
A1 Wu, Zenghui
A1 Rauch, Frank
YR 2020
UL http://medrxiv.org/content/early/2020/09/02/2020.08.31.20183533.abstract
AB This project assessed the prevalence of active and past infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a specialized pediatric institution that did not provide care for coronavirus disease 2019 (Covid-19). The study was performed in Montreal, the city with the highest number of Covid-19 cases in Canada during the early phase of the pandemic. Testing for SARS-CoV-2 RNA in 199 individuals (39 children, 61 accompanying persons, 99 hospital employees) did not reveal active infection in any of the study participants. However, 22 (11%) of study participants had SARSCoV-2 IgG antibodies, indicating prior infection. Ten of these participants did not report symptoms compatible with Covid-19 in the 6 months prior to the study. Thus, although no evidence for active infection was found within the institution, consideration should be given to regular staff testing to detect asymptomatic spreading of SARS-CoV-2. In addition, it could be useful to test accompanying persons in children presenting for surgical procedures.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is an observational study. No intervention was performed.Funding StatementThe study was supported by the Shriners of North America. ELISA IgG antibody plates were donated by Mologic Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of McGill University (study number A05-M45-20B)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.